Epidemiological Characteristics of Chronic Viral Hepatitis in Kazakhstan: Data from Unified Nationwide Electronic Healthcare System 2014-2019.

HBV HCV incidence mortality prevalence survival

Journal

Infection and drug resistance
ISSN: 1178-6973
Titre abrégé: Infect Drug Resist
Pays: New Zealand
ID NLM: 101550216

Informations de publication

Date de publication:
2022
Historique:
received: 10 03 2022
accepted: 09 06 2022
entrez: 5 7 2022
pubmed: 6 7 2022
medline: 6 7 2022
Statut: epublish

Résumé

Viral hepatitis is the leading cause of hepatic cirrhosis and liver-related mortality, yet there are no countrywide epidemiological studies available to date in Kazakhstan. The aim of the study was to perform an estimation of mortality, prevalence and incidence of Hepatitis B and C infections and liver-related complications. Using centralized healthcare data from the Unified National Electronic Health System (UNEHS) for the period 2014-2019, a total of 82,700 registered patients with chronic viral hepatitis B (HBV), C (HCV) and D (HDV) have been extracted based on ICD -10 codes. Crude rates of incidence, prevalence and mortality, as well as age-, sex- and year-specific rates of incidence and mortality per 100,000 population were estimated. Unadjusted and adjusted hazard ratios were estimated using Cox proportional hazards regression modeling. For the total number of 82,700 patients, 56.6% were represented by chronic HCV infection and 43.4% by HBV infection. The prevalence of coinfection was 10% for HBV+HDV and 3.5% for HBV+HCV. Both HBV and HCV were more prevalent among female patients (56%) and among Kazakh ethnic group (64.8%). Males with HBV had a higher probability of death than females; this trend was stronger among male patients with HCV. Russian ethnic groups infected with HBV had a higher risk of death compared to Kazakh and other ethnic groups. Whereas in HCV-infected patients, Russian ethnic group and other ethnic group had similar risk for death, but higher compared to Kazakhs. During the 2014-2019 period, prevalence, incidence and mortality from chronic HBV and HCV infections increased. Despite the disproportionately higher infection rate among females with chronic viral hepatitis, all-cause mortality was more than two-fold higher among males. Higher death rates in Russian ethnic group compared to other ethnicities need to be evaluated in further studies for other confounding factors and associated comorbidities in this group.

Sections du résumé

Background UNASSIGNED
Viral hepatitis is the leading cause of hepatic cirrhosis and liver-related mortality, yet there are no countrywide epidemiological studies available to date in Kazakhstan. The aim of the study was to perform an estimation of mortality, prevalence and incidence of Hepatitis B and C infections and liver-related complications.
Methods UNASSIGNED
Using centralized healthcare data from the Unified National Electronic Health System (UNEHS) for the period 2014-2019, a total of 82,700 registered patients with chronic viral hepatitis B (HBV), C (HCV) and D (HDV) have been extracted based on ICD -10 codes. Crude rates of incidence, prevalence and mortality, as well as age-, sex- and year-specific rates of incidence and mortality per 100,000 population were estimated. Unadjusted and adjusted hazard ratios were estimated using Cox proportional hazards regression modeling.
Results UNASSIGNED
For the total number of 82,700 patients, 56.6% were represented by chronic HCV infection and 43.4% by HBV infection. The prevalence of coinfection was 10% for HBV+HDV and 3.5% for HBV+HCV. Both HBV and HCV were more prevalent among female patients (56%) and among Kazakh ethnic group (64.8%). Males with HBV had a higher probability of death than females; this trend was stronger among male patients with HCV. Russian ethnic groups infected with HBV had a higher risk of death compared to Kazakh and other ethnic groups. Whereas in HCV-infected patients, Russian ethnic group and other ethnic group had similar risk for death, but higher compared to Kazakhs.
Conclusion UNASSIGNED
During the 2014-2019 period, prevalence, incidence and mortality from chronic HBV and HCV infections increased. Despite the disproportionately higher infection rate among females with chronic viral hepatitis, all-cause mortality was more than two-fold higher among males. Higher death rates in Russian ethnic group compared to other ethnicities need to be evaluated in further studies for other confounding factors and associated comorbidities in this group.

Identifiants

pubmed: 35782528
doi: 10.2147/IDR.S363609
pii: 363609
pmc: PMC9248955
doi:

Types de publication

Journal Article

Langues

eng

Pagination

3333-3346

Informations de copyright

© 2022 Ashimkhanova et al.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):533-542
pubmed: 32704164
J Infect. 2000 May;40(3):234-41
pubmed: 10908017
Sci Rep. 2021 Sep 7;11(1):18123
pubmed: 34493797
Health Syst Transit. 2012;14(4):1-154
pubmed: 22894852
Viruses. 2020 Sep 30;12(10):
pubmed: 33008101
J Infect Dis. 2020 Apr 27;221(10):1677-1687
pubmed: 31778167
Lancet Gastroenterol Hepatol. 2021 Oct;6(10):778-780
pubmed: 34384530
Int J Infect Dis. 2021 Mar;104:510-525
pubmed: 33385583
Iran J Public Health. 2014 Feb;43(2):156-61
pubmed: 26060738
Sci Total Environ. 2020 Oct 20;740:139696
pubmed: 32927529
Curr Opin Pharmacol. 2021 Jun;58:62-67
pubmed: 33895531
Iran J Public Health. 2018 Dec;47(12):1845-1853
pubmed: 30788299
Exp Clin Transplant. 2015 Nov;13 Suppl 3:120-2
pubmed: 26640930
Transplant Proc. 2019 Dec;51(10):3360-3363
pubmed: 31733795
BMC Gastroenterol. 2020 Jan 30;20(1):24
pubmed: 32000689
Exp Clin Transplant. 2016 Nov;14(Suppl 3):112-113
pubmed: 27805527
Ann Transplant. 2021 Jul 06;26:e931786
pubmed: 34226437
Gut. 2019 Mar;68(3):512-521
pubmed: 30228220
Ethn Dis. 2010 Spring;20(2):169-73
pubmed: 20503898
Gut. 2007 Jun;56(6):884; author reply 884
pubmed: 17519492
Gastroenterology. 2009 May;136(5):1629-38
pubmed: 19208358
World J Gastroenterol. 2016 Sep 14;22(34):7824-40
pubmed: 27678366

Auteurs

Aiymkul Ashimkhanova (A)

Department of Medicine, Nazarbayev University School of Medicine, Nur-Sultan, Kazakhstan.

Dmitriy Syssoyev (D)

Department of Medicine, Nazarbayev University School of Medicine, Nur-Sultan, Kazakhstan.

Arnur Gusmanov (A)

Department of Medicine, Nazarbayev University School of Medicine, Nur-Sultan, Kazakhstan.

Kakharman Yesmembetov (K)

Department of Medicine III, University Medical Center Aachen, Aachen, Germany.

Arina Yespotayeva (A)

Al-Farabi University, Faculty of Medicine and Healthcare, Almaty, Kazakhstan.

Anara Abbay (A)

Department of Medicine, Nazarbayev University School of Medicine, Nur-Sultan, Kazakhstan.

Aiymzhan Nurpeissova (A)

Department of Medical Information Analysis of Outpatient and Polyclinic Care, Republican Center of Electronic Healthcare, Nur-Sultan, Kazakhstan.

Antonio Sarria-Santamera (A)

Department of Medicine, Nazarbayev University School of Medicine, Nur-Sultan, Kazakhstan.

Abduzhappar Gaipov (A)

Department of Medicine, Nazarbayev University School of Medicine, Nur-Sultan, Kazakhstan.

Classifications MeSH